Experts highlighted recent gene therapy approvals for inherited immune disorders while addressing ongoing challenges in manufacturing, long-term safety, and patient access.
|Articles|June 1, 2003
- Volume 0 0
Healthy Heart Handbook Available
Advertisement
The 2003 edition of The Healthy Heart Handbook for Women offers new information on women?s heart disease and suggestions for reducing the risk of heart-related problems. The 106-page handbook includes updated information on preventing and controlling high blood pressure and on postmenopausal therapy, as well as information about the warning signs of heart attack in women. For a copy, visit the National Heart, Lung and Blood Institute Web site at
Articles in this issue
over 23 years ago
New Strategy Seeks to Improve America's Oral Healthover 23 years ago
Severe Gum Disease May Raise Preeclampsia Riskover 23 years ago
Medication for Menstrual Migrainesover 23 years ago
BP1 Gene Linked to Breast Cancerover 23 years ago
Prenatal Exposure to Alcoholover 23 years ago
Estrogen Patch Minimizes Cardiovascular Riskover 23 years ago
Diabetes and Gum Diseaseover 23 years ago
Bacteria Cause Fresh Breath?or Halitosisover 23 years ago
Drought in Your Mouth?over 23 years ago
NOCC's Goal: Raise AwarenessAdvertisement
Related to this article
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
At the 2026 ASTCT Gene Therapy Summit, experts highlighted how chronic pain, psychological challenges, and neurologic complications may persist despite successful treatment.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
ADA guidance ties monitoring choices to therapy, risk, and preference. Brooke Hudspeth, PharmD, explains how pharmacists help individualize the plan.
Twice-daily metronidazole dosing had outcomes comparable with those of thrice-daily dosing for confirmed anaerobic infections, minimizing drug exposure and cost while maintaining clinical efficacy.
Pharmacists navigate BCMA therapy sequencing in relapsed/refractory multiple myeloma, weighing linvoseltamab logistics, community readiness, safety monitoring, and smoother care transitions.
The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CVS Health to Split Into 2 Public Companies, Separating Retail and Specialty Pharmacy
2
Community Pharmacists Guide Patients New to Glucose Monitoring
3
FDA Approves Tildrakizumab for Adults With Psoriatic Arthritis
4
Is Less More? Comparing Metronidazole Dosing in Confirmed Anaerobic Infections
5